
CyCognito Joins Wiz Integrations (WIN) Platform
PALO ALTO, Calif., April 24, 2025 /PRNewswire/ -- CyCognito, the leader in external exposure management, today announced its partnership with leading cloud security provider Wiz and joins Wiz Integrations (WIN). The integration, launching at the RSA Conference, enables joint customers to combine the visibility and coverage of Wiz's CNAPP with the power of continuous Dynamic Application Security Testing (DAST) and external asset discovery across global organizations—ultimately enabling enhanced cloud security coverage.
There are a number of critical visibility gaps that can compromise a company's security posture in the cloud. Human error in account mapping and CSPM configuration creates dangerous blind spots. Enterprises struggle with unmanaged workloads outside security controls, while M&A introduces subsidiary assets with inconsistent standards. Vendor-transitioned projects contain undocumented vulnerabilities, and third-party services extend the attack surface beyond your perimeter. All of these gaps create exploitable weaknesses that threat actors actively target.
CyCognito addresses these challenges through seedless discovery that automatically identifies unmanaged cloud instances where traditional security tools fall short. By providing an attacker's perspective from outside your network, CyCognito reveals both sanctioned and unsanctioned environments without requiring cloud service provider APIs. Its external attack surface management approach complements CNAPP strategies by providing visibility into coverage gaps and giving cloud security teams visibility into assets they didn't know existed. This comprehensive view enables effective management of dynamic cloud environments.
CyCognito uses DAST to examine running apps for vulnerabilities. CyCognito enables organizations to reach their ideal app sec goals by testing from the network edge—through the infrastructure—and into the application. CyCognito addresses the testing gaps that, until now, organizations have struggled to close.
'By integrating with Wiz, we're bringing the attacker's perspective directly into cloud security programs,' said Randy Streu, SVP Global Channels & Alliances, CyCognito. 'This partnership empowers security teams with both internal and external visibility—combining Wiz's deep cloud-native context with our continuous external discovery to help teams surface, prioritize, and respond to the risks that matter most.'
Mutual customers receive the following benefits:
The integration with Wiz supports a modern cloud security operating model, where security and cloud teams work together across the entire development lifecycle. Wiz's unified platform delivers code-to-cloud context to reduce the attack surface—using shared policies to stop risks earlier in the SDLC and ensure posture is enforced in production. With Wiz Defend, teams can also detect and respond to real-time threats in their cloud environments, enabling complete visibility and control across code, cloud, and runtime.
'We're excited to welcome CyCognito to the Wiz Integration Network,' said Oron Noah, VP of Product, Extensibility & Partnerships at Wiz. 'By combining CyCognito's continuous DAST and external asset discovery with Wiz's comprehensive code-to-cloud context and real-time threat detection, we're enabling our customers to proactively identify exposures, prioritize critical risks, and strengthen their cloud security posture across the entire development lifecycle.'
To learn more about the CyCognito-Wiz integration at RSA, please visit booth #3110.
To see how this integration empowers cloud security teams with greater visibility and control, please visit the dedicated blog page.
About CyCognito
CyCognito is an external exposure management platform that discovers, tests, and prioritizes security risks. The platform provides the deepest, most accurate mapping of external attack surfaces without manual effort or seed inputs, and conducts 80,000+ security tests to identify critical vulnerabilities before attackers can exploit them. Trusted by Fortune 500 companies and government agencies, CyCognito reduces remediation time from months to days. Learn more at https://www.cycognito.com/
View original content: https://www.prnewswire.com/news-releases/cycognito-joins-wiz-integrations-win-platform-302437314.html
SOURCE CyCognito
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
4 hours ago
- Associated Press
Comcast to Participate in Goldman Sachs Investor Conference
PHILADELPHIA--(BUSINESS WIRE)--Aug 19, 2025-- Comcast Corporation (Nasdaq: CMCSA) announced that on Tuesday, September 9, 2025, Mike Cavanagh, President of Comcast Corporation, will participate in the Goldman Sachs Communacopia + Technology Conference. A live webcast of the event will be available on the Company's Investor Relations website at on Tuesday, September 9, 2025, at 11:10 A.M. Eastern Time. An on-demand replay will be available shortly after the conclusion of the presentation. To automatically receive Comcast financial news by e-mail, please visit and subscribe to E-mail Alerts. View source version on CONTACT: Investor Contacts: Marci Ryvicker (215) 286-4781 Jane Kearns (215) 286-4794 Marc Kaplan (215) 286-6527 Press Contacts: Jennifer Khoury (215) 286-7408 John Demming (215) 286-8011 KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA INDUSTRY KEYWORD: ENTERTAINMENT COMMUNICATIONS TECHNOLOGY TV AND RADIO TELECOMMUNICATIONS MEDIA CARRIERS AND SERVICES SOURCE: Comcast Corporation Copyright Business Wire 2025. PUB: 08/19/2025 03:00 PM/DISC: 08/19/2025 03:00 PM
Yahoo
5 hours ago
- Yahoo
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
JUPITER, Fla., Aug. 19, 2025 /PRNewswire/ -- Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB Bridge Award from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) program. The funding will support Myosin Therapeutic's Phase I STAR-GBM dose escalation and expansion trial of MT-125, a first-in-class novel small molecule therapeutic being evaluated in patients with newly diagnosed, MGMT unmethylated glioblastoma. Glioblastoma remains among the most lethal cancers, with median survival measured in months. MT-125 targets non-muscle myosin II, a critical driver of tumor cell invasion, proliferation and treatment resistance, representing a novel therapeutic approach that is distinct from existing standards of care. The STAR-GBM trial will assess the safety, tolerability, and pharmacokinetics of MT-125 in this patient population with significant unmet need. Exploratory endpoints include measures of efficacy, including progression-free survival and overall survival. The NCI SBIR program is one of the most competitive federal funding mechanisms for cancer-focused innovation, providing support to small businesses with technologies that have strong scientific merit, commercial potential, and a clear path to clinical impact. Bridge Awards, which require that matching funds from private capital be raised first, are reserved for companies with promising, later-stage projects that have already demonstrated significant technical progress and the potential to attract substantial private investment. "The NCI Bridge Award was perfectly timed to support our STAR-GBM trial, for which patient enrollment is set to begin in November," said Dr. Courtney Miller, co-founder and CEO of Myosin Therapeutics. "It will enable us to generate the data needed to position the program for later-stage development, potential partnerships, and future expansion into a wider range of patients. Our ultimate goal is to deliver a transformative treatment option for patients who currently face limited or inadequate therapeutic choices." About Myosin TherapeuticsMyosin Therapeutics is a Jupiter, FL-based biotechnology company spun out of The Wertheim UF Scripps Institute (formerly Scripps Research, Florida). The company is focused on developing therapies for neuroscience and oncology indications using a platform that targets molecular nanomotor proteins. For more information, visit Contact: contact@ View original content to download multimedia: SOURCE Myosin Therapeutics Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Monogoto Receives 2025 IoT Evolution Product of the Year Award
Software-Defined Connectivity Cloud Honored for Exceptional Innovation PALO ALTO, Calif., Aug. 19, 2025 /PRNewswire/ -- Monogoto announced today that its Software-Defined Connectivity Cloud has received a 2025 IoT Evolution Product of the Year Award from IoT Evolution World, the leading website covering IoT technologies. Monogoto's platform redefines connectivity by offering a hybrid public, private, and satellite architecture, integrated with zero-trust security, programmable APIs, and developer-first tools. Designed to support intelligent, distributed IoT systems, Monogoto empowers enterprises to deploy and manage secure, scalable connectivity globally, with real-time visibility, automation, and AI-ready performance. "We're honored to be recognized for a solution that enables our customers to innovate without compromising control or security," said Itamar Kunik, Co-Founder & CEO at Monogoto. "This award reflects our commitment to delivering flexible, programmable connectivity for modern IoT ecosystems, from device provisioning to network orchestration and AI." "The solutions selected for the IoT Evolution Product of Year Award reflect the diverse range of innovation driving the multi-billion dollar IoT market today. It is my honor to congratulate Monogoto for their innovative work and superior contribution to the rapidly evolving IoT industry," said Rich Tehrani, CEO of TMC, a co-publisher of IoT Evolution. "It is my pleasure to recognize Software-Defined Connectivity Cloud, an innovative solution that earned Monogoto the 2025 IoT Evolution Product of the Year Award," said Carl Ford, Community Developer at IoT Evolution World. "I look forward to seeing even more innovation from Monogoto in the future." About Monogoto Monogoto is a cloud-based connectivity provider offering secure, programmable, and global cellular connectivity for IoT, Private LTE, and 5G applications. Built on a zero-trust architecture and API-first design, Monogoto enables developers and enterprises to provision, control, and scale connectivity like software — across public networks, private infrastructure, and satellite links. With presence in 180+ countries, Monogoto powers next-generation applications across FinTech, supply chain & logistics, smart utilities, manufacturing, agriculture and more. Learn more at About Crossfire MediaCrossfire Media is an integrated marketing company with a core focus on future trends in technology. We service communities of interest with conferences, tradeshows, webinars and newsletters. Crossfire Media has a partnership with Technology Marketing Corporation (TMC) to produce events and websites related to disruptive technologies. Crossfire Media is a division of Crossfire Consulting, a full-service Information Technology company based in New York. About TMCFor more than 20 years, TMC has been honoring technology companies with awards in various categories. These awards are regarded as some of the most prestigious and respected awards in the communications and technology sector worldwide. Winners represent prominent players in the market who consistently demonstrate the advancement of technologies. Each recipient is a verifiable leader in the marketplace. TMC also provides global buyers with valuable insights to make informed tech decisions through our editorial platforms, live events, webinars, and online advertising. Leading vendors trust TMC, thought leadership, and our events for branding, thought leadership, and lead generation. Our live events, like the ITEXPO #TECHSUPERSHOW, deliver unmatched visibility, while our custom lead generation programs and webinars ensure a steady flow of sales opportunities. Display ads on trusted sites generate millions of impressions, boosting brand reputations. TMC offers a complete 360-degree marketing solution, from event management to content creation, driving SEO, branding, and marketing success. Learn more at TMC Contact:Stephanie ThompsonManager, TMC Awards203-852-6800sthompson@ Monogoto Contact:Carla DeisenrothSVP, Marketingcarla@ Photo - View original content to download multimedia: SOURCE Monogoto 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤